As of 2025-04-24, the Intrinsic Value of Immunovant Inc (IMVT) is -11.27 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.25 USD, the upside of Immunovant Inc is -179.06%.
Based on its market price of 14.25 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 179.06%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.27 - -11.27 | -11.27 | -179.06% |
| P/E | (62.55) - (98.78) | (75.70) | -631.3% |
| DDM - Stable | (10.42) - (23.47) | (16.94) | -218.9% |
| DDM - Multi | (1.11) - (1.96) | (1.42) | -110.0% |
| Market Cap (mil) | 2,420.51 |
| Beta | 0.98 |
| Outstanding shares (mil) | 169.86 |
| Enterprise Value (mil) | 2,045.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 15.89% |
| Cost of Debt | 5.00% |
| WACC | 10.44% |